Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets Journal Article


Authors: Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C. J.; Cohen, S.; Park, J.; Hill, C. E.; Eng, K.; Bareja, R.; Han, T.; Liu, E. M.; Palladino, A.; Di, W.; Gao, D.; Abida, W.; Beg, S.; Puca, L.; Meneses, M.; de Stanchina, E.; Berger, M. F.; Gopalan, A.; Dow, L. E.; Mosquera, J. M.; Beltran, H.; Sternberg, C. N.; Chi, P.; Scher, H. I.; Sboner, A.; Chen, Y.; Khurana, E.
Article Title: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Abstract: In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR) dependence leads to clinically aggressive tumors with few therapeutic options. We used ATAC-seq (assay for transposase-accessible chromatin sequencing), RNA-seq, and DNA sequencing to investigate 22 organoids, six patient-derived xenografts, and 12 cell lines. We identified the well-characterized AR-dependent and neuroendocrine subtypes, as well as two AR-negative/low groups: a Wnt-dependent subtype, and a stem cell-like (SCL) subtype driven by activator protein-1 (AP-1) transcription factors. We used transcriptomic signatures to classify 366 patients, which showed that SCL is the second most common subtype of CRPC after AR-dependent. Our data suggest that AP-1 interacts with the YAP/TAZ and TEAD proteins to maintain subtype-specific chromatin accessibility and transcriptomic landscapes in this group. Together, this molecular classification reveals drug targets and can potentially guide therapeutic decisions. © 2022 American Association for the Advancement of Science. All rights reserved.
Keywords: genetics; androgen; metabolism; cell line, tumor; dna; chromatin; tumor cell line; androgen receptor; castration; receptors, androgen; castration resistant prostate cancer; cell; drug; transcription factor ap 1; transcription factor ap-1; cell component; cancer; humans; human; male; prostatic neoplasms, castration-resistant
Journal Title: Science
Volume: 376
Issue: 6596
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2022-05-27
Start Page: eabe1505
Language: English
DOI: 10.1126/science.abe1505
PUBMED: 35617398
PROVIDER: scopus
PMCID: PMC9299269
DOI/URL:
Notes: Article -- Export Date: 1 July 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yu Chen
    136 Chen
  2. Ping Chi
    177 Chi
  3. Anuradha Gopalan
    421 Gopalan
  4. Michael Forman Berger
    781 Berger
  5. Howard Scher
    1133 Scher
  6. Wassim Abida
    160 Abida
  7. Dong Gao
    28 Gao
  8. Wei   Di
    3 Di
  9. Shangqian   Wang
    20 Wang
  10. Corinne Elizabeth Hill
    7 Hill
  11. Minwei Liu
    25 Liu
  12. Jane Park
    8 Park
  13. Cindy J Lee
    19 Lee
  14. Chen Khuan Wong
    3 Wong
  15. Teng Han
    3 Han